unknown
Stage
1
Investors
About
Vittoria Biotherapeutics is a clinical-stage biotechnology company developing next-generation CAR T-cell therapies using its proprietary SENZA5 platform to treat oncology and immunology conditions.
Explore Vittoria Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.